Asia Pacific Pharmacy Automation Market Size, Share & Trends Analysis Report By Product (Medication Dispensing Systems, Automated Medication Compounding Systems), By End Use, By Country, And Segment Forecasts, 2025 - 2033
Description
Asia Pacific Pharmacy Automation Market Summary
The Asia Pacific pharmacy automation market size was estimated at USD 1.20 billion in 2024 and is projected to reach USD 3.20 billion by 2033, growing at a CAGR of 11.63% from 2025 to 2033. This is attributed to the rising demand for specialty drug prescription-filling solutions due to the increasing incidence of chronic and life-threatening diseases, the rising need to minimize medication errors, and the decentralization of pharmacies. Moreover, an increasing dispensing of medications and technological advancements in automation systems have significantly enhanced the efficiency and accuracy of pharmacy operations.
Increasing Demand for Specialty Drug Prescription Filling Solutions
These drugs are created to manage complex and chronic illnesses such as cancer, autoimmune disorders, and some uncommon diseases. These types of drugs are sensitive, requiring careful preparation, appropriate storage, and exact dosing. With healthcare expanding access to complex therapies, an increasing number of pharmacies are receiving precise prescriptions requiring the advanced and favorable resolution of complex inefficiencies to fulfill the precision needed. In July 2022, Bushu Pharma contributed to the launch of specialty drugs in Japan and across the Asia-Pacific region. Bushu Pharma's "Gateway to Asia" initiative streamlines the importation, inspection, labeling, packaging, and distribution of specialty drugs in Japan and the Asia-Pacific region. This service model simplifies compliance with regulatory requirements and ensures careful handling, increasing the accessibility of specialty medications to meet the rising demand for automated prescription-filling solutions.
Furthermore, the use of automated aids for prescription delays and medication adherence is essential for optimizing treatment processes. Governments and healthcare stakeholders in the Asia Pacific region are increasingly aware of the need to automate prescription-filling procedures. This automation aims to enhance treatment outcomes and ensure safe and timely access to specialty medications, addressing the complex demands of the healthcare environment.
Asia Pacific Pharmacy Automation Market Report Segmentation
This report forecasts revenue growth, regional and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033 For this study, Grand View Research has segmented the Asia Pacific pharmacy automation market report based on product, end use, and country.
The Asia Pacific pharmacy automation market size was estimated at USD 1.20 billion in 2024 and is projected to reach USD 3.20 billion by 2033, growing at a CAGR of 11.63% from 2025 to 2033. This is attributed to the rising demand for specialty drug prescription-filling solutions due to the increasing incidence of chronic and life-threatening diseases, the rising need to minimize medication errors, and the decentralization of pharmacies. Moreover, an increasing dispensing of medications and technological advancements in automation systems have significantly enhanced the efficiency and accuracy of pharmacy operations.
Increasing Demand for Specialty Drug Prescription Filling Solutions
These drugs are created to manage complex and chronic illnesses such as cancer, autoimmune disorders, and some uncommon diseases. These types of drugs are sensitive, requiring careful preparation, appropriate storage, and exact dosing. With healthcare expanding access to complex therapies, an increasing number of pharmacies are receiving precise prescriptions requiring the advanced and favorable resolution of complex inefficiencies to fulfill the precision needed. In July 2022, Bushu Pharma contributed to the launch of specialty drugs in Japan and across the Asia-Pacific region. Bushu Pharma's "Gateway to Asia" initiative streamlines the importation, inspection, labeling, packaging, and distribution of specialty drugs in Japan and the Asia-Pacific region. This service model simplifies compliance with regulatory requirements and ensures careful handling, increasing the accessibility of specialty medications to meet the rising demand for automated prescription-filling solutions.
Furthermore, the use of automated aids for prescription delays and medication adherence is essential for optimizing treatment processes. Governments and healthcare stakeholders in the Asia Pacific region are increasingly aware of the need to automate prescription-filling procedures. This automation aims to enhance treatment outcomes and ensure safe and timely access to specialty medications, addressing the complex demands of the healthcare environment.
Asia Pacific Pharmacy Automation Market Report Segmentation
This report forecasts revenue growth, regional and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033 For this study, Grand View Research has segmented the Asia Pacific pharmacy automation market report based on product, end use, and country.
- Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Medication dispensing systems
- Robots/robotic automated dispensing systems
- Carousels
- Automated dispensing cabinets
- Packaging and labeling systems
- Storage and retrieval systems
- Automated medication compounding systems
- Tabletop Tablet Counters
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Retail Pharmacy
- Inpatient Pharmacies
- Outpatient Pharmacies
- Pharmacy Benefit Management Organizations and Mail-Order Pharmacies
- Country Outlook (Revenue, USD Billion, 2021 - 2033)
- Japan
- China
- India
- Australia
- Singapore
- South Korea
- Hong Kong
- Thailand
- Rest of APAC
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR’s Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.5.1. Commodity Flow Analysis
- 1.6. Data Validation & Publishing
- 1.7. List of Secondary Sources
- 1.8. Research Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segmental Snapshot
- 2.3. Competitive Insights Snapshot
- Chapter 3. Market Variables, Trends, and Scope
- 3.1. Market Lineage
- 3.1.1. Parent Market Analysis
- 3.1.2. Ancillary Market Analysis
- 3.2. Asia Pacific Pharmacy Automation Market- Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Aging Population and Chronic Disease Prevalence:
- 3.2.1.2. Increasing Demand for Specialty Drug Prescription Filling Solutions
- 3.2.1.3. Focus on Patient Safety and Error Reduction
- 3.2.1.4. Technological Advancements and System Integration
- 3.2.1.5. Decentralization of Pharmacies
- 3.2.1.6. Healthcare Infrastructure Expansion
- 3.2.1.7. Government Initiatives and Regulatory Support
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Initial Investment Costs
- 3.2.2.2. Lack of Technical Expertise
- 3.2.2.3. Regulatory and Compliance Issues
- 3.3. Business Environmental Tools Analysis: Asia Pacific Pharmacy Automation Market
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.2. PESTLE Analysis
- Chapter 4. Asia Pacific Pharmacy Automation Market: Product Estimates & Trend Analysis
- 4.1. Asia Pacific Pharmacy Automation Market, By Product: Key Takeaways
- 4.2. Asia Pacific Pharmacy Automation Market: Product Movement & Market Share Analysis, 2024 & 2033
- 4.3. Medication Dispensing Systems
- 4.3.1. Medication Dispensing Systems Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.2. Robots/Robotic Automated Dispensing Systems
- 4.3.2.1. Robots/Robotic Automated Dispensing Systems Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.3. Carousels
- 4.3.3.1. Carousels Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.4. Automated Dispensing Cabinets
- 4.3.4.1. Automated Dispensing Cabinets Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4. Packaging And Labeling Systems
- 4.4.1. Packaging And Labeling Systems Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5. Storage and Retrieval Systems
- 4.5.1. Storage and Retrieval Systems Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.6. Automated Medication Compounding Systems
- 4.6.1. Automated Medication Compounding Systems Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.7. Tabletop Tablet Counters
- 4.7.1. Tabletop Tablet Counters Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- Chapter 5. Asia Pacific Pharmacy Automation Market: End Use Estimates & Trend Analysis
- 5.1. Asia Pacific Pharmacy Automation Market, By End Use: Key Takeaways
- 5.2. Asia Pacific Pharmacy Automation Market: End Use Movement & Market Share Analysis, 2024 & 2033
- 5.3. Retail Pharmacy
- 5.3.1. Retail Pharmacy Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.4. Retail Pharmacy
- 5.4.1. Retail Pharmacy Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.5. Outpatient Pharmacies
- 5.5.1. Outpatient Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.6. Pharmacy Benefit Management Organizations and Mail-Order Pharmacies
- 5.6.1. Pharmacy Benefit Management Organizations and Mail-Order Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- Chapter 6. Asia Pacific Pharmacy Automation Market: Country Estimates & Trend Analysis
- 6.1. Asia Pacific Pharmacy Automation Market, By Country: Key Takeaways
- 6.2. Asia Pacific Pharmacy Automation Market: Country Movement & Market Share Analysis, 2024 & 2033
- 6.3. Japan
- 6.3.1. Key country dynamics
- 6.3.2. Regulatory framework
- 6.3.3. Competitive scenario
- 6.3.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4. China
- 6.4.1. Key country dynamics
- 6.4.2. Regulatory framework
- 6.4.3. Competitive scenario
- 6.4.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 6.5. India
- 6.5.1. Key country dynamics
- 6.5.2. Regulatory framework
- 6.5.3. Competitive scenario
- 6.5.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6. Australia
- 6.6.1. Key country dynamics
- 6.6.2. Regulatory framework
- 6.6.3. Competitive scenario
- 6.6.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7. Singapore
- 6.7.1. Key country dynamics
- 6.7.2. Regulatory framework
- 6.7.3. Competitive scenario
- 6.7.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
- 6.8. South Korea
- 6.8.1. Key country dynamics
- 6.8.2. Regulatory framework
- 6.8.3. Competitive scenario
- 6.8.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 6.9. Hong Kong
- 6.9.1. Key country dynamics
- 6.9.2. Regulatory framework
- 6.9.3. Competitive scenario
- 6.9.4. Hong Kong estimates and forecasts 2021 to 2033 (USD Million)
- 6.10. Thailand
- 6.10.1. Key country dynamics
- 6.10.2. Regulatory framework
- 6.10.3. Competitive scenario
- 6.10.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
- 6.11. Rest of APAC
- 6.11.1. Key country dynamics
- 6.11.2. Regulatory framework
- 6.11.3. Competitive scenario
- 6.11.4. Rest of APAC market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Company Categorization
- 7.2. Company Market Position Analysis, 2024
- 7.3. Strategy Mapping
- 7.4. Company Profiles
- 7.4.1. OMNICELL Inc
- 7.4.1.1. Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Strategic Initiatives
- 7.4.2. BD
- 7.4.2.1. Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Strategic Initiatives
- 7.4.3. Scriptpro LLC
- 7.4.3.1. Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Strategic Initiatives
- 7.4.4. McKesson Corporation
- 7.4.4.1. Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Strategic Initiatives
- 7.4.5. Parata Systems, LLC
- 7.4.5.1. Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Strategic Initiatives
- 7.4.6. ARxIUM
- 7.4.6.1. Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Strategic Initiatives
- 7.4.7. Baxter
- 7.4.7.1. Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Strategic Initiatives
- 7.4.8. KUKA AG
- 7.4.8.1. Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Strategic Initiatives
- 7.4.9. Pearson Medical Technologies
- 7.4.9.1. Overview
- 7.4.9.2. Financial Performance
- 7.4.9.3. Product Benchmarking
- 7.4.9.4. Strategic Initiatives
- 7.4.10. RxSafe, LLC
- 7.4.10.1. Overview
- 7.4.10.2. Financial Performance
- 7.4.10.3. Product Benchmarking
- 7.4.10.4. Strategic Initiatives
- 7.4.11. Swisslog Healthcare AG
- 7.4.11.1. Overview
- 7.4.11.2. Financial Performance
- 7.4.11.3. Product Benchmarking
- 7.4.11.4. Strategic Initiatives
- 7.4.12. Yuyama
- 7.4.12.1. Overview
- 7.4.12.2. Financial Performance
- 7.4.12.3. Product Benchmarking
- 7.4.12.4. Strategic Initiatives
- 7.4.13. Innovation Associates
- 7.4.13.1. Overview
- 7.4.13.2. Financial Performance
- 7.4.13.3. Product Benchmarking
- 7.4.13.4. Strategic Initiatives
- 7.4.14. Talyst
- 7.4.14.1. Overview
- 7.4.14.2. Financial Performance
- 7.4.14.3. Product Benchmarking
- 7.4.14.4. Strategic Initiatives
- 7.4.15. Medacist Solutions Group, LLC
- 7.4.15.1. Overview
- 7.4.15.2. Financial Performance
- 7.4.15.3. Product Benchmarking
- 7.4.15.4. Strategic Initiatives
- 7.4.16. Capsa Healthcare
- 7.4.16.1. Overview
- 7.4.16.2. Financial Performance
- 7.4.16.3. Product Benchmarking
- 7.4.16.4. Strategic Initiatives
- 7.4.17. Touchpoint Medical, Inc.
- 7.4.17.1. Overview
- 7.4.17.2. Financial Performance
- 7.4.17.3. Product Benchmarking
- 7.4.17.4. Strategic Initiatives
- 7.4.18. Accu-chart Plus Healthcare Systems, Inc
- 7.4.18.1. Overview
- 7.4.18.2. Financial Performance
- 7.4.18.3. Product Benchmarking
- 7.4.18.4. Strategic Initiatives
- 7.4.19. Cerner Oracle
- 7.4.19.1. Overview
- 7.4.19.2. Financial Performance
- 7.4.19.3. Product Benchmarking
- 7.4.19.4. Strategic Initiatives
- 7.4.20. Fulcrum Pharmacy Management, Inc.
- 7.4.20.1. Overview
- 7.4.20.2. Financial Performance
- 7.4.20.3. Product Benchmarking
- 7.4.20.4. Strategic Initiatives
- 7.4.21. Cerner Corporation
- 7.4.21.1. Overview
- 7.4.21.2. Financial Performance
- 7.4.21.3. Product Benchmarking
- 7.4.21.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
